| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |